Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Prolyl-4-hydroxylase 3 maintains β cell glucose metabolism during fatty acid excess in mice
Daniela Nasteska, Federica Cuozzo, Katrina Viloria, Elspeth M. Johnson, Alpesh Thakker, Rula Bany Bakar, Rebecca L. Westbrook, Jonathan P. Barlow, Monica Hoang, Jamie W. Joseph, Gareth G. Lavery, Ildem Akerman, James Cantley, Leanne Hodson, Daniel A. Tennant, David J. Hodson
Daniela Nasteska, Federica Cuozzo, Katrina Viloria, Elspeth M. Johnson, Alpesh Thakker, Rula Bany Bakar, Rebecca L. Westbrook, Jonathan P. Barlow, Monica Hoang, Jamie W. Joseph, Gareth G. Lavery, Ildem Akerman, James Cantley, Leanne Hodson, Daniel A. Tennant, David J. Hodson
View: Text | PDF
Research Article Endocrinology Metabolism

Prolyl-4-hydroxylase 3 maintains β cell glucose metabolism during fatty acid excess in mice

  • Text
  • PDF
Abstract

The α-ketoglutarate–dependent dioxygenase, prolyl-4-hydroxylase 3 (PHD3), is an HIF target that uses molecular oxygen to hydroxylate peptidyl prolyl residues. Although PHD3 has been reported to influence cancer cell metabolism and liver insulin sensitivity, relatively little is known about the effects of this highly conserved enzyme in insulin-secreting β cells in vivo. Here, we show that the deletion of PHD3 specifically in β cells (βPHD3KO) was associated with impaired glucose homeostasis in mice fed a high-fat diet. In the early stages of dietary fat excess, βPHD3KO islets energetically rewired, leading to defects in the management of pyruvate fate and a shift from glycolysis to increased fatty acid oxidation (FAO). However, under more prolonged metabolic stress, this switch to preferential FAO in βPHD3KO islets was associated with impaired glucose-stimulated ATP/ADP rises, Ca2+ fluxes, and insulin secretion. Thus, PHD3 might be a pivotal component of the β cell glucose metabolism machinery in mice by suppressing the use of fatty acids as a primary fuel source during the early phases of metabolic stress.

Authors

Daniela Nasteska, Federica Cuozzo, Katrina Viloria, Elspeth M. Johnson, Alpesh Thakker, Rula Bany Bakar, Rebecca L. Westbrook, Jonathan P. Barlow, Monica Hoang, Jamie W. Joseph, Gareth G. Lavery, Ildem Akerman, James Cantley, Leanne Hodson, Daniel A. Tennant, David J. Hodson

×

Figure 7

Prolonged metabolic stress (8 weeks HFD) leads to insulin secretory failure in βPHD3KO islets.

Options: View larger image (or click on image) Download as PowerPoint
Prolonged metabolic stress (8 weeks HFD) leads to insulin secretory fail...
(A and B) Acaca (A) and Acacb (B) expression is similar in βPHD3CON and βPHD3KO islets from animals fed 4 weeks HFD (n = 6 animals/genotype; unpaired t test). (C) Glucose tolerance remains impaired in βPHD3KO mice after 8 weeks HFD feeding (n = 9–11 animals/genotype; 2-way RM ANOVA, Sidak’s test; AUC: unpaired t test). (D) Insulin sensitivity is unchanged in βPHD3KO mice (n = 5 animals/genotype, 2-way RM ANOVA; Sidak’s test; AUC: unpaired t test). (E) Oral glucose tolerance is normal in βPHD3KO mice (n = 6–7 animals/genotype; 2-way RM ANOVA, Sidak’s test; AUC: unpaired t test). (F) Body composition is unchanged in βPHD3KO mice (n = 5 animals/genotype; 2-way ANOVA, Sidak’s test). (G and H) Glucose-stimulated insulin secretion (G) is impaired in βPHD3KO islets after 8 weeks HFD (n = 29–32 replicates, 4 animals/genotype; 2-way ANOVA, Sidak’s test), despite similar insulin content (H) (16–18 replicates, 4 animals/genotype; unpaired t test). (I and J) Glucose-stimulated and KCl-stimulated Ca2+ rises are impaired in βPHD3KO islets, shown by mean traces (I) and quantification (J) (n = 21–24 islets/genotype, 2 animals/genotype; 2-way ANOVA, Sidak’s test). (K and L) Apoptosis is increased in βPHD3KO islets, shown by quantification (K) and representative images (L) (n = 8–9 islets/genotype; unpaired t test). (M) Ddit3, Xbp1, and Hspa5 expression shows no changes in βPHD3KO islets (n = 6–7 animals/genotype; unpaired t test). (N–Q) Islet proliferation (PCNA; N and O) and α cell/β cell ratio (P and Q) are unchanged in βPHD3KO islets (n = 11–18 islets, 3–4 animals/genotype; unpaired t test). (R–T) Images (R) and quantification (S and T) showing increased β cell mass in βPHD3KO mice (scale bar: 530 μm; inset is 5.25× original magnification) (n = 3 animals/genotype, 2-way ANOVA; unpaired t test). Data shown are mean ± SEM. *P < 0.05, **P < 0.01, and NS. Scale bar: 42.5 μm (inset 4× original magnification) unless otherwise stated. PCNA, proliferating cell nuclear antigen; SC, standard chow; HFD, high-fat diet.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts